Circulating-Tumor-Dna on Bioeconhttps://en.bioecon.ru/technologies/circulating-tumor-dna/Recent content in Circulating-Tumor-Dna on BioeconHugoen-USMon, 20 Jul 2026 14:07:15 +0700Liquid biopsy & ctDNA diagnosticshttps://en.bioecon.ru/technology/liquid-biopsy-ctdna-diagnostics/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/liquid-biopsy-ctdna-diagnostics/Blood-based detection and quantification of circulating tumor DNA (ctDNA) for cancer companion diagnostics and molecular residual disease (MRD) monitoring, replacing or supplementing tissue biopsy — led by Guardant Health, Natera and Foundation Medicine in the US, Sysmex Inostics in the EU, MedGenome in India, and Burning Rock Biotech in China.